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Abstract: Lanthanide-doped fluoride up-converting nanoparticles (UCNPs) represent the new 
class of imaging contrast agents which hold great potential for overcoming existing problems 
associated with traditionally used dyes, proteins and quantum dots. In this study, a new kind of 
hybrid NaYF4:Yb,Er/PLGA nanoparticles for efficient biolabeling were prepared through one-pot 
solvothermal synthesis route. Morphological and structural characteristics of the as-designed 
particles were obtained using X-ray powder diffraction (XRPD), scanning and transmission 
electron microscopy (SEM/TEM), energy dispersive spectroscopy (EDS), Fourier transform 
infrared (FTIR) and photoluminescence (PL) spectroscopy, while their cytotoxicity as well as up-
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conversion (UC) labeling capability were tested in vitro toward human gingival cells (HGC) and 
oral squamous cell carcinoma (OSCC). The results revealed coexistence of the cubic (Fm-3m) 
and hexagonal (P63/m) phase in spherical and irregularly shaped nanoparticles, respectively. 
PLGA [Poly(lactic-co-glycolic acid)] ligands attached at the surface of UCNPs particles provide 
their enhanced cellular uptake and enable high-quality cells imaging through a near-infrared 
(NIR) laser scanning microscopy (ex=980 nm). Moreover, the fact that NaYF4:Yb,Er/PLGA 
UCNPs show low cytotoxicity against HGC over the whole concentration range (10–50 μg/mL) 
while a dose dependent viability of OSCC is obtained indicates that these might be a promising 
candidates for targeted cancer cell therapy.
Keywords: upconversion nanoparticles; PLGA; NaYF4:Yb,Er; bioimaging; cancer cell; human 
gingival cell.
1. Introduction
Head and neck cancers represent the sixth most common cancer worldwide, with the 
highest incidence rates in Melanesia, South-Central Asia and Central and Eastern Europe [1]. 
Among them, oral squamous cell carcinoma (OSCC) is the most common malignant epithelial 
neoplasm affecting the oral cavity. The incidence of oral cavity cancer appearance is higher in 
males and as the major risk factors are considered smoking, alcohol use, smokeless tobacco use 
and human papillomavirus (HPV). Early stages of disease are asymptomatic and very similar to 
other mucosal diseases and if diagnosed at advanced stages result with a 5-year survival rate of 
around 50%. Fatal outcomes are mostly caused by local recurrence and neck lymph node 
metastasis [2]. Therefore, advancements in both, early diagnosis and therapy, are necessary and 
most likely will come from innovative non-invasive selective optical techniques [3]. Among the 
various optical diagnostic methods, fluorescence imaging is of immense importance since that 
provides accurate visualization of the molecular and functional processes in the human body [4]. 
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Moreover, with the current progress in designing of the new hybrid multifunctional lanthanide-
doped up-conversion nanoparticles (UCNPs) whose excitation/emission falls into the biological 
tissue transparency window, superior optical diagnostic and targeted drug delivery is expectable 
in the near future [5,6]. Due to efficient two-phonon excitation and the large anti-Stocks shift 
UCNPs are able to emit visible or UV photons under excitation by near-infrared (NIR) light, to 
achieve deeper tissue penetration, and to exhibit higher photochemical stability in comparison 
with a traditionally used fluorophores [7]. The effectiveness of these materials is principally 
dependent on the crystal structure and phonon energy of a host matrix, as well as, on the choice 
and concentration of lanthanide dopants. Efficient lanthanide pairs which can easily upconvert 
low energy photons into higher ones comprise ytterbium (Yb3+) as a sensitizer and erbium (Er3+), 
thulium (Tm3+) or holmium (Ho3+) as activator. The rich energy levels and long-lived 
intermediate excited states of activators provide various energy transfer pathways for UC 
emissions in visible spectra. Following initial Yb3+ excitation by 980 nm laser, energy transfer 
upconversion (ETU), excited state absorption (ESA), photon avalanche (PA), cooperative energy 
transfer (CET) and cross-relaxation (CR) processes take place determining resulting fluorescence 
efficiency of UCNPs [8]. Among many compounds, fluoride based cubic or hexagonal crystal 
lattices of  NaYF4 phase have been extensively studied as the most efficient hosts because of their 
low phonon energy (i.e., 350 cm−1), which minimize harmful non-radiative relaxations, and high 
optical transparence necessary for migration of NIR photons. In particular, hexagonal phase 
exhibits approximately one order of magnitude higher UC emission in comparison to cubic 
counterpart since it possess a higher degree of asymmetry, multisite occupation with lanthanide 
dopant ions and shorter distance among them. Since that particle size also affects the 
luminescence efficiency (higher energy transfer loss is attributed to the higher density of the 
surface defects) different synthesis strategies were developed to highlight tailored performances 
of specially designed core-shell, hybrid and composite UCNPs for cell imaging and tracking, 
drug delivery, photodynamic therapy and target recognition of bio-species [9,10]. Although 
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showing remarkable characteristics during both in vitro and in vivo investigations studied 
structures were usually obtain through complex multi-steps procedure which involves 
decomposition of organometallic compounds in oleic acid and subsequent ligand exchange (or 
oxidation, coating, intercalation, etc.).  Usage of toxic and hazardous substances during synthesis 
raised deep concerns regarding potential toxicity of synthesized UCNPs [11-13]. Recently, it was 
shown that such obtained UCNPs could regain their cytotoxicity upon interaction with cells if 
weakly coordinated surface groups are used to render them biocompatible after synthesis [14]. 
Thus, the safe biological application of UCNPs implies establishing of facile and reliable 
procedure which would minimize the usage of toxic solvents and provide hydrophilic reactive 
surface in situ toward enhanced conjugation of proteins and drugs. One-pot polymer assisted 
hydrothermal approach, originally reported by Wang et al. [15] is a simple procedure which 
enables direct synthesis of water-dispersible UCNPs. To date, it was used for in situ 
functionalization of UCNPs surface with a wide range of biocompatible capping ligands, 
including carboxylic and amine/imine groups of polymers, such as: polyethylenimine (PEI), 
polyacrylic acid (PAA), polyvinylpyrrolidone (PVP) and polyethylene glycol (PEG) [16-18]. 
Among others, we have also shown that PVP-, PEG- and EDTA- assisted hydro/solvothermal 
route, performed in a controlled manner, led to the generation of hydrophilic/biocompatible 
upconverting  particles with a different shape (spherical, rod, prisms, octahedron and desert-rose) 
[19,20]. Here, we reported for the first time usages of poly(lactic-co-glycolic acid) (PLGA) 
during solvothermal synthesis of NaYF4:Yb/Er nanoparticles. PLGA, approved by the United 
States Food and Drug Administration and European Medicine Agency for pharmaceutical 
application and human use, is one of the most widely utilized biodegradable polymer with a 
minimal toxicity associated with its use as scaffolds for tissue engineering or for delivery of 
macromolecular therapeutics [21-23]. For example, PLGA nanoparticles have been proposed as a 
delivery medium of an amphiphilic Gd3+ complex developed for the need of high sensitive 
magnetic resonance imaging (MRI) and imaging guided drug delivery applications [24]. 
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Similarly, it was shown that pH-responsive PLGA(UCNPs/doxorubicin hydrochloride) 
nanocapsules obtained through self-assembly strategy could act as T1-weighted contrast agents 
MRI, cell imaging label and effective chemotherapy drug delivery system [25]. Due to fact that 
PLGA comprises both, hydrophilic and hydrophobic moiety, it was usually used in combination 
with PEG in the form of amphiphilic block-copolymer for posterior UCNPs coating via flash 
nanoprecipitation. PEG-PLGA layer formed in such way provides excellent UCNPs colloidal 
stability in deionized water, buffers and serum media, but in the case of a thicker layer formation 
decrease of the upconversion luminescence was observed [26].  Recently, fabrication of a 
multifunctional nanovector for simultaneous gene delivery and real-time intracellular tracking 
based on UCNPs modified by positively charged amphiphilic polymer and PEG–PLGA 
copolymer was reported [27]. In accordance to the literature, PLGA solely was used, up to date, 
only for coating of the bare UCNPs through intercalation process, but obtained biocompatible 
particles sized around 250 nm exhibited negligible cellular uptake and mild cytotoxicity (cellular 
viability of about 80%) when applied at concentration of 62.5 μg/mL to the human keratinocyte 
and fibroblast cells [28].
In this study, a new kind of hybrid NaYF4:Yb,Er/PLGA nanoparticles for efficient cell 
labeling was prepared through one-pot solvothermal synthesis using non-toxic reagents. Hence, 
PLGA functional groups attached in situ to the UCNPs surface ensure excellent biocompatibility 
without compromising upconverting process. Furthermore, NaYF4:Yb,Er/PLGA UCNPs 
demonstrated dose-dependent cytotoxicity against oral squamous cell carcinoma (OSCC) without 
damaging healthy non-cancerous human gingival cells (HGC), so could be considered as 
promising and reasonably safe candidate for theranostic. 
2. Materials and methods
2.1 Synthesis and characterization of NaYF4:Yb,Er/PLGA UCNPs
All of the chemicals used for PLGA mediated solvothermal synthesis of 
NaY0.8Yb0.17Er0.03F4 were purchased from Sigma-Aldrich. Deionized water was used throughout. 
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Defined stoichiometric amounts of rare earth nitrates (5 mmol in total) were dissolved in 15 ml of 
deionized water and then mixed with 5 ml of NaF solution (1.75-fold excess) and 0.1 g of PLGA 
(lactide:glycolide, 75:25; Mr 66,000-107,000) dissolved in 40 ml of acetone. Obtained mixture 
was stirred for 15 min, transferred to 100 ml Teflon lined autoclave and sealed. Since that PLGA 
is thermally stable until 250 °C under atmospheric pressure [29] synthesis was carried out at 
twice lower temperature of 120 ºC with a continual stirring (100 rpm) for 24 h. After cooling, the 
as-prepared NaYF4:Yb,Er/PLGA UCNPs were washed with acetone by centrifuging (8000 rpm, 
10 min) and dried at 80 ºC for 3 h.
The NaYF4:Yb,Er/PLGA UCNPs were characterized by the X-ray powder diffraction 
(XRPD) using Bruker D8 Discovery equipped with a Cu-K source (= 1.5406 Å). The pattern 
was recorded with a step scan of 0.02º and accounting time of 5 s per step. Powders 
microstructural data were acquired through combined La Bail and Rietveld refinement in Topas 
4.2 software. For cubic - and hexagonal β-NaYF4 phase refinements were carried out in Fm-3m 
(No. 225) and P63/m (No. 176) space groups, respectively. The morphological features of the as-
prepared particles were investigated by means of both, scanning and transmission electron 
microscopy (JEOL JSM-6701F SEM and JEOL JEM 2010 TEM operating at 200 kV at phase 
contrast and selected area electron diffraction (SAED) modes) coupled with energy dispersive 
spectroscopy (EDS). For the aforementioned analyses the particles were suspended in isopropyl 
alcohol and dropped directly on the stub (for SEM) or on lacey carbon film supported on a Cu 
grid after 20 min sonication (for TEM). The SemAfore 5.21 JEOL software was used to construct 
particle size distribution diagrams, while Fourier processing of high resolution TEM images was 
performed with Digital Micrograph 3.7.4 Gatan Inc software. Detection of the PLGA ligands on 
the particles surface was done by Fourier transform infrared spectroscopy (FTIR) using Thermo 
Scientific Nicolet 6700 spectrophotometer (Thermo Fisher Scientific) with a Smart iTR Diamond 
Attenuated Total Reflectance accessory. Spectra were recorded using typically 128 scans at the 
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resolution of 4 cm-1. Dynamic light scattering measurements of the UCNPs hydrodynamic radius 
(RH) were performed on a Malvern Zetasizer Nano ZS in the de-ionized water and medium used 
for testing of the cell viability and imaging. For that purpose, NaYF4:Yb,Er/PLGA UCNPs  were 
dispersed at the concentration of 1mg/mL and passed through a 0.45 μm cellulose syringe filter 
before DLS measurements. Photoluminescence emission measurement was performed at room 
temperature using Spex Fluorolog with C31034 cooled photomultiplier under diode laser 
excitation at 980 nm. From obtained spectrum the chromaticity coordinate calculation was done.
2.2. OSCC and HGC cultures 
Human tumor and healthy gingival tissues were obtained from the patients at the Clinic 
of Maxillofacial Surgery of School of Dental Medicine, University of Belgrade immediately after 
the surgery, with signed informed consent approval from each patient prior to study participation. 
The planning experiments were approved by the Ethical Committee of the School of Dental 
Medicine (36/31), University of Belgrade. 
Tumor tissues were oral squamous cell carcinoma (OSCC) of a tongue. Preparation of the 
cell cultures was performed using slightly modified procedure of Pozzi et al. [30]. Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 20% fetal bovine serum (FBS) and 100 
U/mL penicillin-streptomycin (Sigma-Aldrich, St. Louis, USA) was used to transport the tissue 
sample. The tissue samples were minced with blades into small pieces. The cells were grown in 
DMEM supplemented with 10% FBS and 100 U/ml penicillin-streptomycin seeded onto T25 cell 
culture flasks. The cells were maintained at 37 °C in humidified atmosphere containing 5% CO2. 
The medium was changed every 2-3 days and the cells were passaged prior to 
reaching 80% confluence. To avoid fibroblast contamination in cultures, brief exposure to 
TrypLE Express (Thermo Fisher Scientific, Waltham, USA) was used. OSCC used for the present 
study were obtained after the third passage. 
Human gingival tissues were obtained from three different, healthy patients, aged 19-25 
years, during extraction of the impacted third molar. The gingival tissue was transported in Gibco 
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Dulbecco’s modified Eagle’s F12 medium (D-MEM/F12; Thermo Fisher Scientific), 
supplemented with 20% FBS and 1% antibiotic/antimycotic (ABAM; Thermo Fisher Scientific) 
solution. The gingival tissue was rinsed in phosphate-buffered saline (PBS) from Sigma-Aldrich 
(St. Louis, USA) and subjected to outgrowth isolation method. Tissue was minced into 
approximately 1 mm2 fragments, and placed in 25-cm2 culture flasks with DMEM/F12 
supplemented with 10% FBS and 1% ABAM, and incubated at 37C in 5% CO2. The cells were 
allowed to reach 80% confluence prior to passage. The culture medium was changed every 2-3 
days. HGC after the second passage were used in this study.
2.3. MTT assay
For assessment of cytotoxicity, NaYF4:Yb,Er/PLGA UCNPs suspensions with three 
different concentrations (10, 25 and 50 µg/ml) were prepared. For each concentration, adequate 
mass of NaYF4:Yb,Er/PLGA UCNPs was aseptically weighted and suspended in sterile water, 
shaken vigorously and sonicated for 3 min. OSCC and HGC were seeded in a 96-well plate 
(10000 cells per well) and incubated at 37 °C in humidified 5% CO2 atmosphere. After 24h hours 
100µl of the NaYF4:Yb,Er/PLGA UCNPs were added (10, 25 or 50 µg/ml) in each plate. 
Incubation with the cell cultures was stopped after 24 h by discarding of spent media, and 
medium containing 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT, 0.5 
mg/ml) (Sigma-Aldrich, St. Louis, USA) was added to each well and than incubated for 
additional 4 hours, as previous described by Castiglioni et al. [31]. The supernatant was discarded 
and formazan crystals were dissolved in 100 µL dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. 
Louis, USA) by shaking in duration of 20 minutes at 37 °C. Optical density was measured at 540 
nm using ELISA microplate reader (Enzyme-linked immunosorbent assay) RT- 2100c, Rayto, 
China). Three wells without NaYF4:Yb,Er/PLGA UCNPs were used as a control group.
2.4. Statistical analysis
According to the cytotoxicity test procedure, the experiments were performed in triplicate 
and repeated three times in the independent experiments. Cells viability, expressed by the ratio of 
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absorbance of the cells incubated with UCNPs to that of the cells incubated with culture medium 
only, were given in diagram as the mean ± standard deviation (SD). 
2.5. Cells imaging by laser scanning microscopy
For the visualization of NaYF4:Yb,Er/PLGA UCNPs uptake, the lowest concentration of 
NaYF4:Yb,Er/PLGA UCNPs suspension (10 µg/ml) was filtered through 0.45 µm syringe filter to 
separate large agglomerates and to avoid saturation during visualization. Filtered solution was 
used further for incubation with cells and preparation of samples for laser scanning microscopy. 
Sterilized 22 mm×22 mm glass coverslips were placed in 6-well plates, and 10 000 of OSCC 
and HGC were seeded per coverslip and incubated at 37 °C in humidified atmosphere containing 
5% CO2. The next day cells were exposed to NaYF4:Yb,Er/PLGA UCNPs solution and incubated 
for another 24 hours. Coverslips with adherent cells were gently rinsed with PBS twice and 
fixated with 4% paraformaldehyde (PFA) (Sigma-Aldrich, St. Louis, USA) for 20 minutes. 
Residuals of PFA were washed by PBS (3x3 min), coverslips were dried, 10 l of Mowiol 
(Sigma-Aldrich, St. Louis, USA) was placed on fixated cells, and coverslips were placed on 
microscopic slides with cells positioned in between. Samples were stored in a dark until they 
were observed under confocal microscopy.
The homemade nonlinear laser scanning microscope used in this study was described in 
detail elsewhere [32]. Ti:Sapphire laser (Coherent, Mira 900-F) was used as a laser light source. It 
operates in two regimes. The first regime generates femto-second (FS) pulses at 730nm 
convenient for unlabeled cell imaging since that enables two photon excitation of auto-
fluorescence in cells. Note that two photon excitation here is considered as excitation of the 
molecule with no intermediate levels between ground and excited state and it is not related to 
upconversion process. The second regime comprises generation of continuous wave (CW) 
radiation at 980nm and was used for the excitation of NaYF4:Yb,Er/PLGA UCNPs in cells. Due 
to the long UCNPs lifetime, the scanning rate was reduced during imaging in order to extend 
pixel dwell time. Hence the pixel dwell time was several times longer than fluorescence lifetime. 
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Each fixed cell culture was imaged using Carl Zeiss, EC Plan-NEOFLUAR, 40×1.3 oil 
immersion objective for laser focusing and collection of the fluorescence. A visible interference 
filter (415nm-685 nm) positioned in front of detector is used to remove scattered laser light. Thus, 
the whole visible range has been detected either for auto-fluorescence from cells or up-conversion 
from NaYF4:Yb,Er/PLGA UCNPs in cells.
3. Results and discussion
      3.1. Structural and morphological properties of NaYF4:Yb,Er/PLGA UCNPs
To confirm the composition and the crystallinity of the synthesized NaYF4:Yb,Er/PLGA 
UCNPs XRPD analysis was performed. Pattern presented in Fig.1. reflects that obtained sample 
is a mixture of well crystallized cubic (Fm-3m) and hexagonal (P63/m) phase since all of the 
reflections, i.e. their positions and intensities, are in a good agreement with the reported 01-077-
2042 and 01-016-0334 ICDD data, presented as bottom bar line diagram in the same figure. In 
general, NaYF4 material has three different polymorphs: low temperature cubic, hexagonal and 
high-temperature cubic – whose structure lacks detailed characterization [33].  In a low- 
temperature cubic phase (Fm-3m) there is only one site coordinated by eight fluoride anions over 
which Na+ and RE3+ ions are randomly distributed in the cationic sub-lattice, whereas in the 
hexagonal (P63/m) there are two types of low-symmetry sites at which dopants could be 
arranged. As it is indicated recently, high-temperature cubic phase could be described with the 
same space group as a low-temperature one, but with the well-ordered distribution of sodium and 
RE cations [34]. The unit cell parameters of low-temperature cubic phase and hexagonal one 
crystallized in the NaYF4:Yb,Er/PLGA sample were determined from XRPD data to be (Å): 
a=5.4764(1); and a=5.9785(3), c=3.5088(4); respectively. Since cubic phase prevails in the 
sample (~85 wt%), refinement of this phase was performed starting from the ICSD 6025 card 
data. Decreased occupation of the cation site by Na+ and Y3+ of 0.98(1) and 0.76 (1) corresponds 
well with a nominal compound stoichiometry, while RBragg value of 1.79 reflects good compliance 
11
with the structural model used during refinement. The average crystallite size of 33 (1) nm was 
calculated using volume weighted mean column height broadening modeled by a Voigt function 
while Gaussian microstrain distribution was determined to be 0.113(4). 
The morphological characteristic of the NaYF4:Yb,Er/PLGA UCNPs were evaluated 
based on SEM and TEM analysis, Fig.2. As presented in Fig. 2a, sample is composed of uniform 
and well defined spherical particles with average size around 100 nm. Backscattered electron 
images and EDS chemical analysis (not presented) implied compositional homogeneity and high 
particles purity. As it is notable from SEM, particles are stick together due to the PLGA presence. 
TEM analysis revealed existence of smaller nanoparticles with elongated shape and length up to 
60 nm, Fig.2b. The high resolution TEM image presented at Fig.2c, exposes their good 
crystallinity, clear lattice fringes and the interplanar spacing of 2.98 Å which might be associated 
with a (110) plane of hexagonal phase. Furthermore, diffraction pattern via SAED mode 
presented as inset at the same figure pointed out that all of determined d values are consistent 
with the interplanar spacings of the hexagonal NaYF4 phase (PDF 01-016-0334) confirming 
results derived from XRPD. Cubic NaYF4 phase was detected in somewhat smaller nanoparticles 
with a spherical shape, as it is shown in Fig.2d. Confined growth of NaYF4 nanocrystals was 
presumably caused by the interaction between the lanthanide ions and the carboxyl end groups of 
PLGA, which presence is verified further by FTIR analysis.  
Colloidal size, polydispersity index (PDI) and stability of the NaYF4:Yb,Er/PLGA UCNPs 
solutions were estimated from dynamic light scattering measurements, Fig.S1. While a 
monomodal size distribution was obtained in water (due instant agglomeration of the nanopartcles 
sized below 20 nm), the bimodal one was preserved in a medium over time (24h). As a result, 
slightly higher average hydrodynamic diameter (RHav) of the NaYF4:Yb/Er/PLGA UCNPs was 
detected in water (177 nm, PDI 0.32) than in medium (127nm, PDI 0.31). Minimal changes 
distinguished after one hour, confirms good stability of both colloids (195 nm, PDI 0.32; and 
127nm, PDI 0.31; in water and medium, respectively). With prolongation of time, after 24h, 
12
magnitude of the NaYF4:Yb,Er/PLGA UCNPs RHav in water increased to 488 nm (PDI 0.3), 
whilst stayed unchanged in medium which is further used for cells bioimaging (122nm, PDI 
0.34).
Infrared absorption spectra of pure PLGA and NaYF4:Yb,Er/PLGA UCNPs were 
recorded and presented at Fig.3. Pure PLGA exhibited characteristic absorption bands which are 
classified in accordance to the literature [35] as follows: CH3 and CH2 asymmetric stretching at 
2850 and 2920 cm-1 respectivelly; C=O stretching around 1750 cm-1, CH3 and CH2 symmetric 
angular deformation in the 1500–1250 cm-1 region and C-O ester stretching in the 1300-1150 cm-
1 region. FTIR analysis of NaYF4:Yb,Er/PLGA UCNPs revealed a decreased PLGA absorption 
due to side-chain vibrations as well as low-frequency shifting of its most intense band associated 
to the C=O stretching, which might be due to the carboxylic acid salts formation, O=C–ONa, as it 
was suggested in the literature [36]. This evident that applied synthesis method preserves the 
highly reactive carboxylic acid groups on UCNPs surface which is very important for their 
conjugation with biomolecules containing -NH2 group, like antibodies, streptavidin and DNA, 
creating in that way carriers with high binding potential for targeted imaging and therapy [13].
      3.2. Optical properties of NaYF4:Yb,Er/PLGA UCNPs
The upconversion spectrum of NaYF4:Yb,Er/PLGA UCNPs is presented in Fig.4. 
Following excitation with 980 nm into the 2F5/2 state of Yb3+and subsequent energy transfer from 
Yb3+ to Er3+ ions (and vice versa),  three distinct Er3+ emission bands centered at 520, 539 and 653 
nm are clearly observed in the visible part of spectrum. The double green emissions between 512 
and 533nm and between 533 and 560nm are attributed to the 2H11/2 →4I15/2 and 4S3/2 → 4I15/2 
transitions respectively, while a red emission observed between 630 and 690nm is due to the 4F9/2 
→ 4I15/2 transition. Green band emission at 539 nm, characterized by several narrow lines 
associated with a splitting of the 4S3/2 energy level by the matrix electric field, reflects the 
homogeneous distribution of Er3+ in the NaYF4 phase [20]. On the other hand, the red emission 
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appears due to a direct population of 4F9/2 level from 4I13/2 level (following the non-radiative decay 
from 4I11/2 level which is intensified in nanocrystals) and a non-radiative relaxation from 4F7/2 
through the 2H11/2 and 4S3/2 levels. As a result, the integrated green to red emission ratios of 0.62 
and CIE of (0.37, 0.61) determines the final color output of NaYF4:Yb,Er/PLGA UCNPs, Fig.4. 
Photostability of the NaYF4:Yb,Er/PLGA UCNPs emission was also traced during 1h, Fig.S2. As 
one could see, exceptionally stable UC luminescence signal was recorded.
    3.3. Cytotoxicity of NaYF4:Yb,Er/PLGA UCNPs 
The viability of HSCC and HGC after 24h exposure to NaYF4:Yb,Er/PLGA UCNPs at 
concentrations of 10, 25 and 50 μg/ml, expressed in terms of percentages compared to the 
surviving cells in the control group is presented at Fig.5. As it is notable from Fig.5, the viability 
of HGC was highly preserved after 24h exposure, being above 88% for all examined 
concentrations of NaYF4:Yb,Er/PLGA UCNPs. At the same time, the tolerance of OSCC was 
found variable with the increase of NaYF4:Yb,Er/PLGA UCNPs concentration. Only in the case 
of the lowest concentration viability of OSCC implied non-significant cytotoxicity of 89%, while 
higher NaYF4:Yb,Er/PLGA concentrations exerted in them certain level of cytotoxicity, i.e. cell 
viability of only 60% was detected. This is quite surprising since cancer cells are usually highly 
resistant to therapeutics. Obtained data regarding preserved viability of HGC corroborated well 
by recent conclusions about cytotoxicity of bare and PLGA coated NaYF4:Yb:Er UCNPs tested 
on human skin cells [28]. Guller et al. [28] used the solvent evaporation technique for posterior 
formation of PLGA shell over the NaYF4:Yb/Er nanoparticles that have been synthesized through 
decomposition of rare earth trifluoroacetates in oleic acid/octadecene mixture. Although the 
authors reported much lower internalization capacity, higher sensitivity of keratinocytes than of 
fibroblasts has been achieved, emphasizing the importance of studying normal cells. As it will be 
shown latter, maintaining of the high HGC viability in this study is not a consequence of the 
lower internalization of NaYF4:Yb,Er/PLGA UCNPs in them, so evaluated differences in OSCC 
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viability indicates that synthesized UCNPs could be useful in therapeutic treatments of cancer 
cells.  
    3.4. In vitro laser scanning microscopy imaging of OSCC and HGC 
For the evaluation of the NaYF4:Yb,Er/PLGA UCNPs capability to be internalized in 
OSCC and HGC, the lowest NaYF4:Yb,Er/PLGA UCNPs concentration of 10 µg/mL has been 
used. For this concentration, no significant cytotoxicity has been observed in both OSCC and 
HGC (Section 3.3) and therefore, it could be considered as the most promising concentration for 
diagnostic purpose. 
Visualization of the OSCC and HGC labeled with the NaYF4:Yb,Er/PLGA UCNPs was 
done using of a safe 980 nm laser intensity of 6 and 7.5mW, respectively. The size of the imaged 
region was approximately 200x200 m2. Images of the OSCC are shown in Fig.6. The top row, 
left panel shows bright field image of the sample. A pseudo color image of the cells auto-
fluorescence upon femto-second excitation at 730 nm is shown in top-right panel. Bottom row - 
left panel shows the pseudo color image of the NaYF4:Yb,Er/PLGA UCNPs upon CW excitation 
at 980 nm.  Overlapping of the latter two images clearly implicates that observed fluorescence 
spots are related to the non-specific uptake of UCPNs through cell membrane and their 
positioning in a cytoplasmic area around cells nuclei. Size of the fluorescence spots indicates 
UCNPs aggregation in cells.   
The consistent finding of the UCNPs internalization in the HGC has been drawn from 
Fig.7, which presents HGCs labeled in the same way as OSCC. The fact that UCNPs are mainly 
localized in the vicinity of the cells nuclei, without visible entering in, designates that UCNPs 
didn’t provoke gene disruption. In order to show comparable level of the NaYF4:Yb,Er/PLGA 
UCNPs internalization in OSCC and HGC, quantification of the UCNPs signal from the Figs. 6 
and 7, as well as additional one which show labeling of a single OSCC were done, and results 
obtained are presented in Supplement File (Figs.S3 and S4). Significant cellular internalization of 
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NaYF4:Yb,Er/PLGA UCNPs coupled with the preserved cells viability indicates that these could  
be useful theranostics for oral cavity cancers.  
As it is pointed out before, the amount of literature showing cells viability and labeling 
with UCNPs is respectable and summarized in many reviews, but great majority is focused on 
cancer cells testing. At the same time, data about mucosal cytotoxicity and drug deliver capacity 
of UCNPs tested on primary cultures and normal cells are limited and inconsistent in achieved 
results due to the considerable disparity of the UCNPs characteristics and type of protective 
organic shell used [37-39]. Thus, it is not easy to compare these with data presented in this study 
but it is worth to note that realistic UCNP-assisted imaging depth nowadays is estimated to be 
up to 1 cm [28], which corresponds well with the depth of skin and mucosa, so successful OSCC 
and HGC labeling with NaYF4:Yb,Er/PLGA UCNPs holds promise for these to be used as 
theranostic agents in the future. 
 
4. Conclusion
In conclusion, we have demonstrated the successful fabrication of the new 
NaYF4:Yb,Er/PLGA UCNPs that could be used as probes for NIR-excited fluorescence (in vitro) 
imaging of human mucosal cells. Comprehensive morphological and structural analyses implied 
crystallization of a low-temperature cubic phase in spherical nanoparticles (~100 nm), as well as, 
hexagonal one in elongated nanocrystals (~ 60 nm). As a consequence of the upconversion, green 
emission (between 512 and 533nm and between 533 and 560nm) and red emission (between 630 
and 690nm) are both prominent in spectra, yielding a final light green output (CIE 0.37, 0.61). 
PLGA functional groups present at NaYF4:Yb,Er UCNPs surface make them accessible for 
further conjugation with biologically important molecules, while in the present form enable non-
specific cellular uptake without compromising cells viability. Moreover, evidences about lower 
cytotoxicity under significant internalization of NaYF4:Yb,Er/PLGA UCNPs in the vicinity of the 
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cell nucleus without gene disrupting, represent an important step toward application of UCNP-
based particles for diagnosis or the treatment of cancer cells.
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Figures Captions: 
Fig.1. XRPD pattern of NaYF4:Yb,Er/PLGA UCNPs (black), refined structure (red) and 
difference curve (gray); Standard patterns of cubic (PDF 01-077-2042) and hexagonal (PDF 01-
016-0334) NaYF4 phase are given as bottom bar line diagram 
Fig.2 SEM (a) and TEM (b-d) images of NaYF4:Yb,Er/PLGA UCNPs. Corresponding particle 
size distribution histograms are given as insets in a and b; SAED inset in c represents d values of 
the interplanar spacing of hexagonally crystallized elongated nanoparticles, while FFT (inset in d) 
confirms cubic crystal cell arrangements in a spherical ones 
Fig.3 FTIR of pure PLGA and NaYF4:Yb,Er/PLGA UCNPs
Fig. 4. Up-converted spectrum of NaYF4:Yb,Er/PLGA UCNPs excited at 980 nm and 
corresponding CIE diagram (given as inset) 
Fig.5 MTT assay comparing viability of OSCC and HGC incubated with NaYF4:Yb,Er/PLGA 
UCNPs for 24 h. 
Fig.6. Images of OSCC following 24 h incubation with 10 μg/ml of NaYF4:Yb,Er/PLGA: bright 
field (top-left) and cells auto-fluorescence upon femto-second excitation at 730 nm (top-right), 
pseudo color image of the NaYF4:Yb,Er/PLGA UCNPs upon CW excitation at 980 nm (bottom-
left) and their positioning in cells, revealed through co-localization of the cell auto-fluorescence 
and the UCNPs emission (bottom-right)
Fig.7. Images of HGC following 24 h incubation with 10 μg/ml of NaYF4:Yb,Er/PLGA: bright 
field (top-left) and cells auto-fluorescence upon femto-second excitation at 730 nm (top-right), 
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pseudo color image of the NaYF4:Yb,Er/PLGA UCNPs upon CW excitation at 980 nm (bottom-
left) and their positioning in cells, revealed through co-localization of the cell auto-fluorescence 
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Fig. S1.  Hydrodynamic radius distribution over time of NaYF4:Yb,Er/PLGA UCNPs (1 mg/mL) 
in water (a) and medium used for testing of cell viability and imaging (b). 
Fig. S2.  Photostability of the NaYF4:Yb,Er/PLGA UCNPs. The emission intensity was traced 
during 1h (CW laser, 980 nm, power density 2MW/cm2)
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Fig.S3. Quantification of the NaYF4:Yb,Er/PLGA UCNPs uptake in cells): left Fig.6 
(OSCC, 42%) and right Fig.7 (HGC, 33%) 
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Fig.S4. Quantification of the NaYF4:Yb,Er/PLGA UCNPs uptake in single OSCC: 21%
